logo
Colts WR Michael Pittman Jr. leaves practice with apparent injury

Colts WR Michael Pittman Jr. leaves practice with apparent injury

Reuters05-06-2025
June 5 - Indianapolis Colts wide receiver Michael Pittman Jr. left practice early on Thursday with an apparent injury, according to multiple reports.
Pittman went to the ground during an 11-on-11 play but it was not clear if it was from contact. He stayed down for a few seconds and then limped off on his own. He later went with a member of the team's medical staff into the locker room and didn't return to practice.
The 27-year-old started 14 of the 16 games he played last season and caught 69 of 111 targets for 808 yards and three touchdowns. He revealed in April that he played through a fractured back that ultimately was determined would not require surgery. He told the Indianapolis Star that doctors fully cleared him in March.
For his career, Pittman has 405 catches for 4,470 yards and 18 TDs. His best season was in 2023, when he caught 109 passes for 1,152 yards and four TDs.
Indianapolis selected Pittman in the second round (34th overall) of the 2020 NFL Draft.
--Field Level Media
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Newport must hit high standards at Grimsby
Newport must hit high standards at Grimsby

BBC News

time29 minutes ago

  • BBC News

Newport must hit high standards at Grimsby

Newport County cannot let their standards drop when they travel to Grimsby Town in League Two, says boss David Exiles have made a promising start to life under Hughes by taking four points from two league games, drawing with Notts County and winning at Crawley also beat Barnet on penalties in the Carabao Cup before putting in a spirited performance when knocked out 1-0 by Championship Millwall on who left his role as Manchester United Under-21s coach for the job this summer, is encouraged by what he has seen in advance of Saturday's fixture at Blundell Park (15:00 BST)."The reaction from the supporters was really positive around the levels of intent and purpose in our play, that's really important that the crowd are with us," said the manager after the Millwall game."That's the benchmark for us, we need to know when we start a game what the expectations are and the standards that underpin the performance."Newport made eight changes to their XI to face Millwall and were also boosted by the return from injury of defender or midfielder Ciaran Brennan and winger Michael Spellman off the have made an unbeaten start to the season with an opening day 3-0 win over Crawley, 3-3 draw at Harrogate and 3-1 cup win against Shrewsbury on Tuesday.

One in four US adults with diabetes used a GLP-1 drug last year, survey finds
One in four US adults with diabetes used a GLP-1 drug last year, survey finds

Reuters

time29 minutes ago

  • Reuters

One in four US adults with diabetes used a GLP-1 drug last year, survey finds

Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly (LLY.N), opens new tab and Ozempic from Novo Nordisk ( opens new tab are approved in the United States for treating type 2 diabetes. They are sold as Zepbound and Wegovy, respectively, for weight loss and are being tested for other conditions. Use of the injectable drugs was highest among adults with diabetes aged 50–64 at 33.3%, reflecting the more significant disease burden in this group, the report said. A quarter or 25.3% of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8% among those 65 and older. The data are from a nationally representative annual survey of U.S. adults aged 18 and older that was conducted in person and with follow-up by phone in 2024. In 2024, for the first time, participants in the annual survey who had diabetes were asked if they were using the Lilly or Novo blockbusters or other GLP-1 drugs to lower blood sugar or lose weight. The drugs mimic the activity of a hormone that regulates blood sugar levels, slows digestion and helps people feel full for longer. Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply. Roughly 31% of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28% of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens. Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3%, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5% and 26.2%, respectively, the survey found. Only 12.1% of Asian non-Hispanic adults with diabetes used the drugs, which may reflect disparities in access or adoption of the therapies.

Venus Williams set for remarkable US Open comeback at the age of 45 after shock return to tennis
Venus Williams set for remarkable US Open comeback at the age of 45 after shock return to tennis

Daily Mail​

time29 minutes ago

  • Daily Mail​

Venus Williams set for remarkable US Open comeback at the age of 45 after shock return to tennis

Two-time former US Open champion Venus Williams has been handed a wild card into this month's tournament at the age of 45. The seven-time Grand Slam winner made a surprise comeback to tennis earlier this summer after more than a year out of the sport, and she will be back under the bright lights in New York later this month. Williams showed she can still compete after beating fellow American Peyton Stearns in the first round at the Washington Open last week. And now the former world No 1 is set to become the oldest singles player to compete at Flushing Meadows since Renee Richards, aged 47 in 1981. It will be Williams' 25th appearance at the New York major, 25 years after she first won it in 2000. She is also on the entry list for the new-look mixed doubles event alongside another American, Reilly Opelka. The decision to play at Flushing Meadows comes soon after she opened up on the depths of her recent health struggles, a year on from having surgery to remove fibroids from her uterus. The tennis icon, who recently confirmed her engagement to her actor boyfriend Andrea Preti, took a 16-month break from tennis due to the issue, returning to the court back in July. Now, for the first time, Williams has revealed just how much her condition was impacting her life away from tennis in a moving Instagram post 12 months on from her operation in New York. 'On this day 1 year ago I was having surgery, an open myomectomy to remove fibroids and a large focal adenomyoma that was imbedded in the muscle of my uterus,' Williams wrote on Instagram. 'What a difference a year makes! I played my first tournament in over 16 months and I am now preparing for the US Open. This post is in celebration of the last day of fibroid awareness month. There can be happy endings!'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store